Need professional-grade analysis? Visit stockanalysis.com
$12.81B
31.67
N/A
N/A
Medpace Holdings Inc (MEDP) trades on United States in USD. The company is classified in the Industrials sector under the Biotechnology industry. The stock currently trades at $417.29, down 1.58% from the previous close.
Over the past year, MEDP has traded between a low of $291.73 and a high of $620.59. The stock has gained 34.5% over this period. It is currently 32.8% below its 52-week high.
Medpace Holdings Inc has a market capitalization of $12.81B, with a price-to-earnings ratio of 31.67.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Side-by-side comparison against top Industrials peers.